Magnetic resonance spectroscopy in temporal lobe epilepsy

Neurology

Volumn 44, Issue 8, 1994, Pages 1411-1417

  Connelly, A ^a   Jackson, G D ^a   Duncan, J S ^a   King, M D ^a   Gadian, David G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; CREATINE PHOSPHATE; CREATININE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; INTRACTABLE EPILEPSY; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOCREATINE; PROGNOSIS;

EID: 0028031101     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.8.1411     Document Type: Article

References (36)

1. Crombie DL, Cross KW, Fry RJ, Pinsent RJ, Watts CA. A survey of the epilepsies in general practice: a report of the research committee of the Royal College of General Practitioners. BMJ 1960;2:416-422.
2. Granieri E, Rosati G, Tola R, et al. A descriptive study of epilepsy in the district of Coppara, Italy, 1964-1978. Epilepsia 1983;24:502-514.
3. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota 1940-1980. Epilepsia 1991;32:429-445.
4. Hauser W. The natural history of temporal lobe epilepsy. In: Lüders HA, ed. Epilepsy surgery. New York: Raven Press, 1992:133-141.
5. Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM. Outcome with respect to seizures. In: Engel J Jr, ed. Surgical treatment of the epilepsies. 2nd ed. New York: Raven Press, 1993:609-621.
6. Cascino GD, Jack CJ, Parisi JE, et al. MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with temporal lobe epilepsy: pathologic correlation and prognostic importance. Epilepsy Res 1992;11:51-59.
7. Babb TL, Brown WJ. Pathological findings in epilepsy. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1987:511-540.
8. Ashtari M, Barr WB, Schaul N, Bogerts B. Three-dimensional fast low-angle shot imaging and computerized volume measurement of the hippocampus in patients with chronic epilepsy of the temporal lobe. AJNR Am J Neuroradiol 1991;12:941-947.
9. Baulac M, Granat O, Gao X, Laplane D. Hippocampal sclerosis and temporal lobe epilepsy: a MRI study. Epilepsia 1991;32:2-3.
10. Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GCA, Bladin PF. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology 1990;40:1869-1875.
11. Matsuda K, Yagi K, Mihara T, Tottori T, Watanabe Y, Seino M. MRI lesion and epileptogenic focus in temporal lobe epilepsy. Jpn J Psychiatry Neurol 1989;43:393-400.
12. Lencz T, McCarthy G, Bronen RA, et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol 1992;31:629-637.
13. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 1992;115:1001-1015.
14. Ronen RA, Cheung G, Charles JT, et al. Imaging findings in hippocampal sclerosis: correlation with pathology. AJNR Am J Neuroradiol 1991;12:933-940.
15. Jackson GD, Berkovic SF, Duncan JS, Connelly A. Optimizing the diagnosis of hippocampal sclerosis using magnetic resonance imaging. AJNR Am J Neuroradiol 1993;14:753-762.
16. Jackson GD, Connelly A, Duncan JS, Griinewald RA, Ga-dian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993;43: 1793-1799.
17. Cross JH, Jackson GD, Neville BGR, et al. Early detection of abnormalities in partial epilepsy using magnetic resonance. Arch Dis Child 1993;69:104-109.
18. Falconer MA. Mesial temporal (Ammon’s horn) sclerosis as a common cause of epilepsy: aetiology, treatment and prevention. Lancet 1974;2:767-770.
19. Bruton CJ. The neuropathology of temporal lobe epilepsy. Oxford, UK: Oxford University Press, 1988:1-158.
20. Margerison JH, Corsellis JAN. Epilepsy and the temporal lobes. Brain 1966;89:499-530.
21. Roller JK, Zaczek R, Coyle JT. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43: 1136-1142.
22. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Im-munohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131-134.
23. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte type-2 astrocyte progenitors and immature oligodendrocytes in vitro. J Neurochem 1992;59:55-61.
24. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
25. Connelly A, Cross JH, Gadian DG, Jackson GD, Kirkham FJ, Vargha-Khadem F. Focal brain abnormalities in intractable epilepsy of childhood. In: Proceedings of the Society of Magnetic Resonance in Medicine, 10th Annual Meeting, San Francisco, CA. 1991:224.
26. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW. 1H MR spectroscopic imaging detects neuronal loss more sensitively than MRI in focal epilepsy. In: Proceedings of the Society of Magnetic Resonance in Medicine, 11th Annual Meeting, Berlin. 1992:213.
27. Cendes F, Andermann F, Preul MC, Arnold DL. Proton MR spectroscopic imaging in temporal lobe epilepsy [abstract]. Neurology 1993;43(suppl 2):A223.
28. Gadian DG, Connelly A, Duncan JS, et al. 1H magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol Scand Suppl 1994; suppl 152:116-121.
29. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26-30.
30. Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976;24:71-85.
31. Austin SJ, Connelly A, Gadian DG, Benton JS, Brett EM. Localized 1H NMR spectroscopy in Canavan’s disease: a report of two cases. Magn Reson Med 1991;19:439-445.
32. Royston P. Constructing time-specific reference ranges. Stat Med 1991;10:675-690.
33. Royston P. Editorial. PET and SPECT in epilepsy. Lancet 1989;1:135-137.
34. Kuzniecky R, Elgavish GA, Hetherington HP, Evanochko WT, Pohost GM. In vivo 31P nuclear magnetic resonance spectroscopy of human temporal lobe epilepsy. Neurology 1992;42:1586-1590.
35. Laxer KD, Hubesch B, Sappey-Marinier D, Weiner MW. Increased pH and inorganic phosphate in temporal seizure foci, demonstrated by 31P MRS. Epilepsia 1992;33:618-623.
36. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Husted CA, Weiner MW. Lateralization of human focal epilepsy by 31P magnetic resonance spectroscopic imaging. Neurology 1992;42:2011-2018.